Nice Insight Overview

Where Do 
Orphan Drugs 
Go From Here?

Nigel Walker

Nice Insight

Viral Vector Manufacturing

Accelerating The Development of Viral Vector Manufacturing Processes

Richard Snyder, Ph.D.; Clive Glover, Ph.D.; Rajiv Vaidya, Ph.D.; Matt Niloff

Thermo Fisher Scientific

Executive Q&A

Q&A: Building a Successful CDMO Brand

Ampersand Capital Partners

Biological Materials

Keys to Successful Storage, Management and Transport of Biological Materials

Gulam Jaffer

Yourway

Regulatory Starting Materials (RSMs)

Integrated Outsourcing from RSMs to APIs

Scott Martin; Randall Andrews

Albemarle Fine Chemistry Services

Biopharma

Bioprocess of the Future: What’s In it for Biomanufacturers?

Merrilee Whitney

MilliporeSigma

Recombinant Proteins

New Facility Presents Manufacturing Solutions for Recombinant Proteins

Paul Magreta

Grifols Recombinant Protein CDMO

Lean Delivery

Reducing Waste with Lean Delivery in Facility Design and Construction

J. Lee Emel; Matthew Khair

CRB USA

Parenteral Solutions

Supporting Small and Emerging Pharma through Collaboration and Specialized Expertise

Marga Viñes

Grifols

Microbial Fermentation

The Renaissance of Microbial Fermentation

Vladas Algirdas Bumelis

Northway Biotechpharma

Cell & Gene Supply Chain

Managing the Complexity of the Supply Chain for Cell and Gene Therapies

Sascha Sonnenberg

Marken

Stem Cell Therapy

Exploring the Efficacy of Stem Cells in Reversing Age-Related Frailty

Geoff Green

Longeveron

Commercialization

Supporting Commercialization with Specialized Technologies

Joseph Szczesiul

UPM Pharmaceuticals

Tradeshow

Social Networking and Information Exchange at China Pharma Week

CPhI & P-MEC China

Serialization Update

Revisiting the Global Serialization Landscape

Michael Kinsella

Servier

Company Overview

Come Home to BioVectra

BIOVECTRA

Chiral Synthesis

Applying Enzymatic Synthesis for Chiral Molecules

Juliette Martin, Ph.D.; Sergio Kreimerman, Ph.D.

Seqens

Orphan Drug Development

An Expanding Orphan Drug Market

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

Orphan Drug Development

Managing the Risks Associated with Orphan Drug Development and Manufacturing

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

Orphan Drug Development

Navigating the Road to Successful Orphan Drug Commercialization and Launch

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac